FINAL BILL REPORT
This analysis was prepared by non-partisan legislative staff for the use of legislative members in their deliberations. This analysis is not a part of the legislation nor does it constitute a statement of legislative intent.
C 150 L 16
Synopsis as Enacted
Brief Description: Allowing the prescription of a schedule II controlled substance to treat certain disease states and conditions.
Sponsors: Senate Committee on Health Care (originally sponsored by Senators Rivers, Keiser, Cleveland, Miloscia and Chase).
Senate Committee on Health Care
House Committee on Health Care & Wellness
Background: The Controlled Substances Act prohibits practitioners from prescribing amphetamines or Schedule II non-narcotic stimulants except for the treatment of specific disease states or conditions as set forth in statute and rule. Currently, Schedule II non-narcotic stimulants are permitted to be prescribed for the treatment of narcolepsy, depression, multiple sclerosis, and other listed medical conditions.
Summary: Schedule II amphetamines or non-narcotic stimulants may be prescribed for any disease state or condition for which the United States Food and Drug Administration has approved an indication.
Votes on Final Passage:
June 9, 2016